April 5, 2017

April 5, 2017

You Never Know: Twenty Years since Stage IV and Counting

By Dennis Fried – Patient Although it’s not the usual way of doing things, I’ll come to the moral of the story first: You never know. When you’re healthy and everything is going well, the fact that you never know is not a comforting thought. We want to feel

April 5, 2017

What You Should Know as a CLL Caregiver

In March of 2006, my wife Barbara received a phone call telling her that she had been diagnosed with a disease that neither of us had ever heard of – CLL. The doctor’s explanation of this blood cancer included the frigh

April 5, 2017

Watch and Wait: Professor Chris Fegan from Wales “GETS” CLL

By Brian Koffman, MD and Chris Fegan, MB, MD, FRCP, FRCPath Listen To Audio: Dr. Fegan and I met at a CLL-AN (CLL Advocacy Network) Horizon Forum in Belgrade, Serbia in November 2016 where we discussed the stress of being diagnosed with leukemia in general and in particular,

April 5, 2017

Ibrutinib for Watch and Wait? My Story

I was diagnosed with CLL in July 2013. I had a blood test for a sore throat. The lymphocyte count was only 5 – borderline – but it was a shock. My wife and I met with the oncologist who told us we were on “watch and wait”, with

April 5, 2017

Richter Transformation

In 1928, Dr. Richter described a patient with chronic lymphocytic leukemia (CLL), who progressed to develop an aggressive large cell lymphoma. Richter syndrome (RS), also called Richter transformation, is now understood to describe the development of an aggressive lymphoma in patients with CLL or small lymphocytic lymphoma (SLL).

April 5, 2017

Autoimmune Problems in CLL (chronic lymphocytic leukemia)

By Brian Koffman, MD Introduction: We all understand that CLL is a disease of the immune system, but we need to keep in mind that its dysfunction can be manifested both as its diminished capacity to fight off infections and secondary cancers, and its increased tendencies to attack our

April 5, 2017

CLL Society Poster Presentation from ASH 2016

Factors That Influence Patient Treatment Decision Making in the Era of Novel Agents: An Internet-Based Survey of 281 Patients with CLL 2016 ASH abstract:

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

April 5, 2017

You Never Know: Twenty Years since Stage IV and Counting

What You Should Know as a CLL Caregiver

Watch and Wait: Professor Chris Fegan from Wales “GETS” CLL

Ibrutinib for Watch and Wait? My Story

Richter Transformation

Autoimmune Problems in CLL (chronic lymphocytic leukemia)

CLL Society Poster Presentation from ASH 2016

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT